LANOXIN®
(digoxin) Tablets, USP
125 mcg (0.125 mg) Scored I.D. Imprint Y3B (yellow)
250 mcg (0.25 mg) Scored I.D. Imprint X3A (white)
[GlaxoSmithKline]
ADVERSE REACTIONS
CLINICAL PHARMACOLOGY
CONTRAINDICATIONS
DESCRIPTION
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
INDICATIONS AND USAGE
OVERDOSAGE
PRECAUTIONS
WARNINGS
LANOXICAPS®
(digoxin solution in capsules)
100 mcg (0.1 mg) I.D. Imprint B2C (yellow)
200 mcg (0.2 mg) I.D. Imprint C2C (green)
[GlaxoSmithKline]
ADVERSE REACTIONS
CLINICAL PHARMACOLOGY
CONTRAINDICATIONS
DESCRIPTION
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
INDICATIONS AND USAGE
OVERDOSAGE
PRECAUTIONS
WARNINGS
LANOXIN®
(digoxin)
Injection
500 mcg (0.5 mg) in 2 mL (250 mcg [0.25 mg] per mL)
[GlaxoSmithKline]
ADVERSE REACTIONS
CLINICAL PHARMACOLOGY
CONTRAINDICATIONS
DESCRIPTION
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
INDICATIONS AND USAGE
OVERDOSAGE
PRECAUTIONS
WARNINGS
LANOXIN®
(digoxin)
Injection Pediatric
100 mcg (0.1 mg) in 1 mL
[GlaxoSmithKline]
ADVERSE REACTIONS
CLINICAL PHARMACOLOGY
CONTRAINDICATIONS
DESCRIPTION
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
INDICATIONS AND USAGE
OVERDOSAGE
PRECAUTIONS
WARNINGS
DIGOXIN Oral Solution, USP
50 mcg (0.05 mg) per mL
[Roxane Laboratories]
ADVERSE REACTIONS
CLINICAL PHARMACOLOGY
CONTRAINDICATIONS
DESCRIPTION
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
INDICATIONS AND USAGE
OVERDOSAGE
PRECAUTIONS
WARNINGS
Digoxin Injection, USP
Rx only
[Baxter Healthcare Corporation]
ADVERSE REACTIONS
CLINICAL PHARMACOLOGY
CONTRAINDICATIONS
DESCRIPTION
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
INDICATIONS AND USAGE
OVERDOSAGE
PRECAUTIONS
WARNINGS
LANOXIN®
(digoxin) Tablets, USP
125 mcg (0.125 mg) Scored I.D. Imprint Y3B (yellow)
250 mcg (0.25 mg) Scored I.D. Imprint X3A (white)
[GlaxoSmithKline]
ADVERSE REACTIONS
CLINICAL PHARMACOLOGY
CONTRAINDICATIONS
DESCRIPTION
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
INDICATIONS AND USAGE
OVERDOSAGE
PRECAUTIONS
WARNINGS
Digoxin (digoxin) TABLET
[CARACO PHARMACEUTICAL LABORATORIES, LTD.]
ADVERSE REACTIONS
CLINICAL PHARMACOLOGY
CONTRAINDICATIONS
DESCRIPTION
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
INDICATIONS AND USAGE
OVERDOSAGE
PRECAUTIONS
WARNINGS
LANOXICAPS®
(digoxin solution in capsules)
100 mcg (0.1 mg) I.D. Imprint B2C (yellow)
200 mcg (0.2 mg) I.D. Imprint C2C (green)
[GlaxoSmithKline]
ADVERSE REACTIONS
CLINICAL PHARMACOLOGY
CONTRAINDICATIONS
DESCRIPTION
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
INDICATIONS AND USAGE
OVERDOSAGE
PRECAUTIONS
WARNINGS
LANOXIN®
(digoxin)
Injection
500 mcg (0.5 mg) in 2 mL (250 mcg [0.25 mg] per mL)
[GlaxoSmithKline]
ADVERSE REACTIONS
CLINICAL PHARMACOLOGY
CONTRAINDICATIONS
DESCRIPTION
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
INDICATIONS AND USAGE
OVERDOSAGE
PRECAUTIONS
WARNINGS
DIGOXIN INJECTION, USP
[Hospira]
LANOXIN®
(digoxin)
Injection Pediatric
100 mcg (0.1 mg) in 1 mL
[GlaxoSmithKline]
ADVERSE REACTIONS
CLINICAL PHARMACOLOGY
CONTRAINDICATIONS
DESCRIPTION
DOSAGE AND ADMINISTRATION
HOW SUPPLIED
INDICATIONS AND USAGE
OVERDOSAGE
PRECAUTIONS
WARNINGS